Natco Pharma Ltd - 524816 - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2019
Un-audited Financial Results for the quarter and half year ended 30th September, 201912-11-2019
12-11-2019
NATCO Pharma to launch insecticide
Natco Pharma Limited has announced a technical product from its Crop Health Sciences division for Chlorantraniliprole (CTPR), a broad spectrum insecti11-11-2019
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO's 1st key product in Crop Health Sciences for India- Chlorantraniliprole11-11-2019
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earning call for Q2 and half year ended FY20 at 11.00 a.m. IST on November 13, 201906-11-2019
NATCO PHARMA LTD. - 524816 - Board to consider Second Interim Dividend
With reference to the earlier announcement dated November 04, 2019 regarding Board Meeting Intimation for Results, Natco Pharma Ltd has now informed BSE that the Board may consider declaration of 2nd Interim Divided, if any, for the Financial Year 2019-2020 at the Board Meeting scheduled to be held on November 12, 2019.05-11-2019
Natco Pharma Ltd - 524816 - Update on board meeting
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve The Board Meeting to be held on 12/11/2019 to consider Un audited Financial Results for the quarter and half year ended 30th September 2019 and consideration of 2nd Interim Dividend, if any, for the Financial year 2019-202005-11-2019
NATCO PHARMA LTD. - 524816 - Board Meeting Intimation for Intimation Of Board Meeting
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results for the Quarter and Half Year ended September 30, 201904-11-2019
NATCO PHARMA LTD. - 524816 - Shareholding for the Period Ended September 30, 2019
Natco Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here10-10-2019
Natco Pharma Ltd - 524816 - Comnpliance Certificate For The Period Ended 30Th September, 2019
Comnpliance certificate for the period ended 30th September, 201910-10-2019
NATCO PHARMA LTD. - 524816 - Comnpliance Certificate For The Quarter Ending September 30 2019
Comnpliance certificate for the quarter ending september 30 201909-10-2019